doi: 10.1111/imj.15920. Online ahead of print. 1 Woolcock Institute of Medical Research, Sydney, NSW, Australia. 2 Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia. 3 Faculty of Medicine and Health, University of Sydney, NSW, Australia. 4 Princess Alexandra Hospital, Ipswich Road, Woolloongabba, QLD, Australia. doi: 10.1111/imj.15920.
Conclusions: Patients with hypersomnias of central origin assessed in 2 specialised Australian clinics demonstrate comparable clinical characteristics to other published cohorts internationally, however available pharmacological agents in Australia do not reflect international standards of care.